Chronic Lymphocytic Leukemia
Sequencing BTK inhibitor therapy in CLL: treatment considerations and emerging strategies
This podcast explores sequencing strategies and treatment considerations for BTK inhibitors in chronic lymphocytic leukemia (CLL). Jennifer Brown, MD, PhD,…
Date: 30th June 2026
The evolving role of BTK inhibitors in CLL
This VJHemOnc podcast explores the evolving role of BTK inhibitors in chronic lymphocytic leukemia (CLL). Constantine Tam, MBBS (Hons), MD,…
Date: 1st May 2026
Top CLL updates from ASH 2025: novel BTKi monotherapy and combination approaches, BTK degraders, & more
This podcast features updates in chronic lymphocytic leukemia (CLL) from ASH 2025. Talha Munir, MBBS, MRCP, FRCPath, PhD, Leeds Teaching…
Date: 18th December 2025
The management of CLL in resource-limited settings: guideline development and ongoing projects
VJHemOnc recently attended the International Workshop on Chronic Lymphocytic Leukemia (XXI iwCLL 2025) in Krakow, Poland, where there was a…
Date: 16th October 2025
Listener Q&A special: expert insights on CLL, myeloma, and lymphoma
Welcome to the first episode of our Blood Cancer Awareness Month special on VJHemOnc. In this podcast, leading experts answer…
Date: 12th September 2025
Key HemOnc updates from ASCO 2025: myeloma, lymphoma, MPNs, & more!
VJHemOnc recently attended the 2025 ASCO Annual Meeting in Chicago, IL, where we gained insights into the latest advancements in…
Date: 30th June 2025
Updates to the ESMO CLL clinical practice guidelines and implications for relapsed therapy
This episode features leading experts Paolo Ghia, MD, Vita-Salute San Raffaele University, Milan, Italy, and Arnon Kater, MD, PhD, University…
Date: 8th May 2025
Updates to the ESMO CLL clinical practice guidelines: implications for frontline treatment
In this VJHemOnc podcast, experts Barbara Eichhorst, MD, University Hospital Cologne, Cologne, Germany, Lydia Scarfò, MD, Vita-Salute San Raffaele University…
Date: 25th April 2025
Post-ASH CLL highlights: BTK inhibitors & degraders, bispecific antibodies, & more!
VJHemOnc recently attended the 66th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, CA, where we…
Date: 10th January 2025
CAR T-cells and bispecific antibodies in the treatment of NHL: updates from iwNHL 2024
Today’s podcast features discussions from the 21st International Workshop on Non-Hodgkin Lymphoma (iwNHL) which took place in Nice, France. You…
Date: 15th October 2024
A focus on the use of artificial intelligence to personalize blood cancer care
Welcome to the final episode of VJHemOnc’s Blood Cancer Awareness Month special series! This episode focuses on the role of…
Date: 30th September 2024
A focus on the psychosocial impacts of living with blood cancer
Welcome to the second episode of VJHemOnc’s Blood Cancer Awareness Month special series! Today’s episode focuses on the psychosocial impacts…
Date: 18th September 2024
